EP Biocomposites Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Net Income	11.34	11.5	5.76	8.09	3.58	1.9
Depreciation & Amortization	1.09	1.01	1	0.66	0	-
Other Operating Activities	-0.39	-0.23	0.33	3.43	0.97	0.7
Change in Accounts Receivable	-37.23	-31.36	12.35	-64.49	-3.45	-18.11
Change in Inventory	-5.73	-0.19	1.67	-7.33	-3.39	-6.68
Change in Accounts Payable	9.42	17.53	-10.13	15.53	1.8	27.83
Change in Other Net Operating Assets	-4.01	-10.69	-18.91	1.29	0.83	1.34
Operating Cash Flow	-25.51	-12.44	-7.94	-42.8	0.35	6.97
Operating Cash Flow Growth	-	-	-	-	-95.05%	-
Capital Expenditures	-2.27	-2.36	-0.22	-4.74	-0.03	-
Other Investing Activities	0.46	0.73	0.45	0.06	0.03	-
Investing Cash Flow	-1.81	-1.63	0.22	-4.69	0	-
Long-Term Debt Issued	-	5.2	-	41.11	-	-
Total Debt Issued	22.93	5.2	-	41.11	-	0.15
Long-Term Debt Repaid	-	-	-28.29	-	-0.03	-
Net Debt Issued (Repaid)	24.1	5.2	-28.29	41.11	-0.03	0.15
Issuance of Common Stock	-	-	63.5	8.03	-	3
Other Financing Activities	-1.92	-0.35	-7.13	-1.56	-	-3.18
Financing Cash Flow	22.18	4.86	28.08	47.57	-0.03	-0.03
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-	-
Net Cash Flow	-5.14	-9.22	20.36	0.08	0.32	6.94
Free Cash Flow	-27.78	-14.8	-8.17	-47.55	0.32	6.97
Free Cash Flow Growth	-	-	-	-	-95.44%	-
Free Cash Flow Margin	-24.27%	-12.94%	-11.45%	-58.99%	1.08%	20.45%
Free Cash Flow Per Share	-16.47	-8.80	-5.59	-55.72	0.85	-
Cash Interest Paid	1.92	0.35	2.03	1.56	-	-
Cash Income Tax Paid	6.34	4.06	3.63	1.64	0.06	-
Levered Free Cash Flow	-30.73	-16.43	8.81	-48.59	-0.18	-
Unlevered Free Cash Flow	-29.54	-16.21	10.08	-47.61	-0.18	-
Change in Net Working Capital	39	24.44	-3.23	51.76	3.03	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.